Asahi Kasei Medical completes new assembly plant for Planova™ virus removal filters
DÜSSELDORF,
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240529908325/en/
Planova™ S20N (left), Planova™ BioEX (right) (Photo: Business Wire)
The bioprocess business of
Planova™ cellulose hollow-fiber membrane filters, developed specifically for removing viruses from biotherapeutic products, were launched in 1989, followed by Planova™ BioEX hydrophilic PVDF hollow-fiber membrane filters in 2009. Both product lines have earned wide recognition among pharmaceutical manufacturers for their outstanding contribution to the safety of biopharmaceuticals, and their adoption has expanded worldwide. A next-generation line of cellulose hollow-fiber membrane filters, Planova™ S20N, was launched in 2022 featuring robust virus removal capability and simplified operation, and has been highly regarded among customers.
With heightened standards throughout the world for the viral safety of biotherapeutics and advances in the development of monoclonal antibodies and other biopharmaceuticals, global demand for virus removal filters is expected to continue growing. To further ensure stable supply,
Outline of the new Planova™ assembly plant
Location: Nobeoka, Miyazaki,
Construction period: Groundbreaking in
For more information, visit https://planova.ak-bio.com/
About Asahi Kasei
Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529908325/en/
North America Contact:
christian.okeefe@ak-america.com
Europe Contact:
sebastian.schmidt@asahi-kasei.eu
Source: